Cambridge Innovation Capital (jersey) Ltd - Net Worth and Insider Trading
Cambridge Innovation Capital (jersey) Ltd Net Worth
The estimated net worth of Cambridge Innovation Capital (jersey) Ltd is at least $44 Million dollars as of 2024-09-20. Cambridge Innovation Capital (jersey) Ltd is the 10% Owner of Bicycle Therapeutics PLC and owns about 1,751,437 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $44 Million. Details can be seen in Cambridge Innovation Capital (jersey) Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cambridge Innovation Capital (jersey) Ltd has not made any transactions after 2019-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cambridge Innovation Capital (jersey) Ltd
Cambridge Innovation Capital (jersey) Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cambridge Innovation Capital (jersey) Ltd owns 1 companies in total, including Bicycle Therapeutics PLC (BCYC) .
Insider Ownership Summary of Cambridge Innovation Capital (jersey) Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-29 | 10 percent owner |
Cambridge Innovation Capital (jersey) Ltd Latest Holdings Summary
Cambridge Innovation Capital (jersey) Ltd currently owns a total of 1 stock. Cambridge Innovation Capital (jersey) Ltd owns 1,751,437 shares of Bicycle Therapeutics PLC (BCYC) as of May 29, 2019, with a value of $44 Million.
Latest Holdings of Cambridge Innovation Capital (jersey) Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-29 | 1,751,437 | 25.40 | 44,486,500 |
Holding Weightings of Cambridge Innovation Capital (jersey) Ltd
Cambridge Innovation Capital (jersey) Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Cambridge Innovation Capital (jersey) Ltd has made a total of 0 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years. The most-recent trade in Bicycle Therapeutics PLC is the acquisition of 314,286 shares on May 29, 2019, which cost Cambridge Innovation Capital (jersey) Ltd around $4 Million.
Insider Trading History of Cambridge Innovation Capital (jersey) Ltd
- 1
Cambridge Innovation Capital (jersey) Ltd Trading Performance
GuruFocus tracks the stock performance after each of Cambridge Innovation Capital (jersey) Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cambridge Innovation Capital (jersey) Ltd is -40.92%. GuruFocus also compares Cambridge Innovation Capital (jersey) Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cambridge Innovation Capital (jersey) Ltd within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cambridge Innovation Capital (jersey) Ltd's insider trading performs compared to the benchmark.
Performance of Cambridge Innovation Capital (jersey) Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.48 | | | | | |
| Relative Return to S&P 500(%) | -24.18 | | | | | |
Cambridge Innovation Capital (jersey) Ltd Ownership Network
Cambridge Innovation Capital (jersey) Ltd Owned Company Details
What does Bicycle Therapeutics PLC do?
Who are the key executives at Bicycle Therapeutics PLC?
Cambridge Innovation Capital (jersey) Ltd is the 10 percent owner of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .
Bicycle Therapeutics PLC (BCYC) Insider Trades Summary
Over the past 18 months, Cambridge Innovation Capital (jersey) Ltd made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 19,509 shares made by Kevin Lee , a net sale of 5,905 shares made by Alistair Milnes , and a net sale of 5,905 shares made by Michael Skynner .
In summary, during the past 3 months, insiders sold 7,268 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 7,268 shares. During the past 18 months, 44,258 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 44,258 shares.
Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicycle Therapeutics PLC Insider Transactions
Cambridge Innovation Capital (jersey) Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Cambridge Innovation Capital (jersey) Ltd. You might contact Cambridge Innovation Capital (jersey) Ltd via mailing address: /o Bicycle Therapeutics Limited, B900 Babraham Research Campus, Cambridge X0 Cb22 3at.
Discussions on Cambridge Innovation Capital (jersey) Ltd
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
